Short-term Effect of Podiatric Callus Debridement on Plantar Pressure in Diabetic Neuropathic Patients
- Conditions
- Diabetic NeuropathiesPlantar Callus
- Interventions
- Procedure: Callus debridement
- Registration Number
- NCT06357884
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Diabetes peripheral neuropathy (DPN) affects up to 50% of the diabetes population. In the diabetic neuropathic foot, it commonly manifests as loss of protective sensation, foot deformity and skin dryness. Alongside with day-to-day weightbearing activities, this can lead to formation of callus over plantar pressure points. Studies have proven that callus formation leads to high plantar pressure and increased risk of diabetic foot ulcers. For podiatrists, diabetic foot screening and treatment is our daily practice. Plantar callus are commonly treated by sharp debridement to relief pressure from the hard skin build up and thus reducing the risk of ulceration. However, the effectiveness of callus sharp debridement is not commonly studied in researches. Only a few studies in the past evaluated the effectiveness of callus treatment by different outcome measurements. Among those studies only 2 were specifically done in diabetic patients, in which one reported results of diabetic neuropathic patients. All the available studies used peak plantar pressure only as their pedobarographic outcome measure. In this study, the treatment effect of podiatric sharp debridement of callus in diabetic neuropathic patients will be evaluated using a range of pedobarographic parameters and Foot and Ankle Outcome Score (FAOS) questionnaire. The immediate and short-term (3-4 weeks) effect of sharp debridement in DPN patients with callus could be quantified. Change in loading pattern could also be analysed based on different areas of the foot.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- Age 18 or older
- Active out-patient status in Podiatry department of Princess Margaret Hospital
- Men and women
- Ambulatory
- Diagnosis of type I or II diabetes
- Failed peripheral neurological assessment (Vibration perception threshold >25 volts or unable to detect one or more sites of 4-point 10g Semmes-Weinstein monofilament test)
- Presence of plantar callus
- Compliance with instructions (in Chinese or english)
- Ability to read and write (in Chinese or english)
- Peripheral vascular disease
- Painful neuropathy
- Charcot deformity
- Undergone any form of callus debridement in the past 6 weeks
- Active foot ulcer
- Any dermatological condition other than callus that causes hyperkeratosis (e.g. verruca pedis, eczema, tinea pedis)
- Any musculoskeletal condition that affects balance and gait
- Allergic to chlorhexidine gluconate or alcohol
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Callus debridement Callus debridement Callus debridement which aligns with routine clinical practice of the Princess Margaret Hospital Podiatry Department.
- Primary Outcome Measures
Name Time Method Peak plantar pressure (PPP) (unit: kPa) Before treatment, immediately after treatment and 3-4 weeks post-treatment The maximum or highest pressure within foot
- Secondary Outcome Measures
Name Time Method Forefoot to rearfoot peak pressure ratio (F/R ratio) Before treatment, immediately after treatment and 3-4 weeks post-treatment Forefoot to rearfoot peak plantar pressure ratio
Peak pressure gradient (PPG) (unit: kPa/cm) Before treatment, immediately after treatment and 3-4 weeks post-treatment Spatial change in pressure around location of the peak pressure
Foot and Ankle Outcome Score (FAOS) Before treatment, 1 week after treatment and 3-4 weeks post-treatment Patient-reported outcome measurement (PROM) tool that is calculated using 42 Likert scale questions which are organised into 5 sub-categories: symptoms, pain, activities of daily living (ADL), sports and quality of life (QOL)
Pressure time integral (PTI) (unit: kPa*sec) Before treatment, immediately after treatment and 3-4 weeks post-treatment The amount of pressure relative to the time that the pressure is present
Trial Locations
- Locations (1)
Podiatry Department, Princess Margaret Hospital
ðŸ‡ðŸ‡°Hong Kong, Hong Kong